What
is hepatitis B?
Hepatitis B is a virus that causes inflammation of the liver. Chronic (long-lasting) hepatitis B can cause liver cell damage, which can lead to cirrhosis (scarring of the liver) and cancer. It is estimated that 5,000 people die each year in the United States due to the complications of cirrhosis and liver cancer as a result of HBV.

How
common is hepatitis B?
According to Centers for Disease Control and Prevention (CDC), it is estimated that 1.25 million people in the United States have chronic HBV. There were an estimated 78,000 new HBV infections in the United States in 2001.

How
can I get hepatitis B?
HBV is transmitted through direct contact with blood, semen,
or vaginal secretions.
- Hepatitis B can
be transmitted through unprotected vaginal, anal, or oral sex. In adolescents
and adults, this is the most common mode of transmission.
- HBV can also be
transmitted by injecting drug users who share needles or other injecting
equipment contaminated with HBV-infected blood.
- Although tattoo,
body piercing, and acupuncture needles may transmit HBV, these exposures
account for only a small proportion of reported cases in the United
States.
- Mothers who have
HBV can pass it on to their babies during birth.
Although rarely,
transmission may occur in the following ways:
-
Saliva can be a
means of transmission through bites. However, transmission has not been
documented to occur as a result of other types of exposure to saliva,
including kissing.
-
The risk of transmission
from blood transfusion is currently low in the U.S. since blood banks
screen all donated blood.
HBV is found in transmittable
levels in body fluids including:
- Semen
- Vaginal secretions
- Saliva
- Blood
HBV has also been
found in low concentrations in other body fluids, though these fluids
have NOT been associated with transmission:
-
Tears
-
Urine
-
Feces
-
Breast milk
-
Cerebrospinal
fluid
HBV is not spread through food or water or by casual
contact.

What
are the signs or symptoms of hepatitis B?
Many adults have few or no symptoms. Symptoms may mimic
the flu and can include:
-
Anorexia (loss
of appetite)
-
Malaise (feeling
of ill-health)
-
Fatigue (feeling
tired all the time)
-
Nausea and vomiting
-
Abdominal pain
-
Dark urine
-
Jaundice (yellowing
of the skin and eyes)
-
Rash or arthritis
may occur prior to the onset of other symptoms (during the prodromal
or early acute stage).
A few patients (1%)
have a more severe course of illness and may experience sudden and severe
liver failure within a short period of time after infection. These people
may suddenly collapse with fatigue, have jaundice, and develop swelling
in their abdomen. This can be fatal if not treated immediately.

How
can I find out if I have hepatitis B?
Your health care provider can confirm HBV by using a special
blood test to detect HBV particles or antibodies in the blood. Blood tests
can determine whether a person has acute or chronic hepatitis.
HBV is not usually
included in routine blood tests, so patients may have to request the test
from their health care provider.
There are three standard blood tests for HBV:
-
HBsAg (looks for
hepatitis B surface antigens): This test detects the presence and levels
of virus in the blood. When this test is positive or reactive, it means
that the person is infected with HBV at the present time and can pass
the virus to others.
-
Anti-HBs (looks
for antibody to the hepatitis B surface antigen): If this test is positive
or reactive, it means that the person is immune, either as a result
of having had the disease previously or from receiving the hepatitis
B vaccine. This person cannot pass the virus to others.
-
Anti-HBc (antibody
to hepatitis B core antigen): This is usually present in chronic carriers,
who can pass the virus to others. However, if it is present with a positive
anti-HBs test, then it is associated with recovery from a previous infection,
and this person is not a carrier.
In many settings,
a health care provider will run all 3 of the above tests and interpret
the results based on the outcome of all 3.
HBV usually takes
between 3 weeks to 2 months to show up in the blood. It may take up to
two months after infection for a Hepatitis B test to be accurate.
If chronic HBV is
suspected, other tests may be ordered. These tests can help to decide treatment
options and may include:
-
Ultrasound: tests for signs of liver damage and cancer
-
Liver biopsy: detects signs of liver damage and cancer
-
Liver function
test: tests to see if enzymes are higher than normal levels,
which indicates damage to liver cells.
-
E-antigen test: detects e-antigen, a viral protein that is put out by HBV-infected
cells. This test is often used to monitor the effectiveness of some
HBV therapies.
After receiving the hepatitis B vaccine, the following
people may benefit from antibody confirmatory testing in order to be sure
the vaccine is working. The test should be performed within 2 months after
completion of the series or it may not give accurate results.
-
A person whose
sex partner has chronic hepatitis B.
-
A person whose
immune system is compromised (for instance, if someone living with AIDS).
-
A person whose
job exposes him or her to human blood.
-
A child who is
born to an HBV-positive mother.
Babies born to infected
mothers should get two anti-HBs tests at aged 9 to 15 months to be certain
that they are making antibodies, a sign that the vaccine has worked well.
(Babies of HBV-infected mothers are not tested at birth but are automatically
given the HBIG and the first shot of the hepatitis B vaccine series.)

What
can I do to reduce my risk of getting hepatitis B?
VACCINATION BEFORE EXPOSURE TO HBV: Hepatitis
B is preventable through vaccination. Since hepatitis D can only coexist
with hepatitis B, getting vaccinated against hepatitis B also protects
you against hepatitis D.
-
The HBV vaccine
is given in a series of three doses.
-
The first and
second doses must be given at least one month apart.
-
The first and
third doses must be given at least 4 months apart.
-
If a dose is missed,
it should be given as soon as possible.
-
The series should
not be restarted if a dose is missed.
-
Routine booster
doses of the HBV vaccine are NOT currently recommended.
-
Consult your health
care provider for more information about the HBV vaccine and if it is
right for you.
-
HIV can impair
the response to the hepatitis vaccine.
-
A new combination
vaccine called Twinrix has been approved for protection from both HAV
and HBV in persons 18 and older. It reduces the total number of injections
for vaccination from both viruses from five to three.
Hepatitis B vaccine
has been recommended as a routine infant vaccination since 1991 and as
a routine adolescent vaccination since 1995. It is recommended for everyone
18 years of age and younger and for adults over 18 who are at risk for
HBV infection. (However, anyone seeking immunity from HBV may be vaccinated.)
Vaccination against hepatitis B is recommended for those who are at high
risk of infection, including:
-
Health care professionals
-
Clients/staff of
institutions for the developmentally disabled
-
Sexually active
men who have sex with men
-
Household/sexual
contacts of chronic HBV carriers
-
Travelers to and
immigrants from countries with high incidence of HBV
-
Sexually active
heterosexual men and women, including:
- those who have
had another STD recently diagnosed (hepatitis B infection with an
HIV infected individual is more likely to lead to chronic HBV)
- those who have
had more than one sex partner in the preceding six months
- those who
have received treatment in an STD clinic
- those who
are sex workers or prostitutes
-
Injecting and non-injecting
drug users
-
Hemodialysis patients
-
Recipients of
certain blood products
-
Inmates of long-term
correctional facilities.
IMMUNE GLOBULIN
(IG) AFTER EXPOSURE TO HBV: Post exposure treatment to prevent illness
(Immune globulin and HBV vaccine); if a person is exposed to hepatitis
B and has NOT been vaccinated before the exposure:
-
For unvaccinated
individuals who have had recent exposure to someone with acute hepatitis
B, a dose of hepatitis B immune globulin (HBIG) may prevent illness.
-
The hepatitis
B vaccine given with HBIG is also recommended. (The hepatitis B vaccine
in conjunction with HBIG is more effective than administering the hepatitis
B vaccine alone.)
-
Both should be
administered within 7 days after the exposure, as treatment is recommended
even without testing.
-
Since 1985, all
plasma units for preparation of immune globulin have been screened for
HIV.
SEXUAL PREVENTION:
-
Abstinence and
mutual monogamy between two uninfected partners also offer a high level
of protection.
-
Latex condoms
offer effective prevention during vaginal and anal sex by reducing contact
with infected bodily fluids (semen, vaginal secretions and blood).
-
A non-lubricated
latex condom can be used for mouth-to-penis contact. Household plastic
wrap, dams or a latex condom cut lengthwise and opened flat can reduce
the risk of transmission during mouth-to-vulva or oral-anal contact.
NON-SEXUAL PREVENTION:
-
Avoid contact with
infected blood or other body fluids directly or on objects such as needles,
razors, toothbrushes, etc.
-
Clean surfaces
contaminated with blood or other body fluids with a solution of 1 part
household bleach and 10 parts water.
-
Cover cuts, sores,
and rashes with bandages.

What
is the treatment for hepatitis B?
Treatment considerations for HBV vary depending on whether
the infection is acute or chronic. Always consult your health care provider
for specific recommendations and treatment options.
Acute (newly acquired):
-
No specific treatment
is available for acute HBV infection.
-
Most patients
with acute viral hepatitis experience a self-limited illness (one that
runs a defined, limited course), and go on to recover completely.
-
There is no accepted
therapy and no restrictions on diet or activity.
-
In most cases,
hospitalization should be avoided, to prevent spread of the virus to
other patients. It should, however, be considered for patients who are
severely ill.
-
Your health care
provider can recommend the best options based on your individual needs
for care.
Chronic (persistent):
-
Interferon is used
to help stop the replication of HBV. It is called an antiviral agent.
Interferon has been 40 percent effective in eliminating chronic HBV
infection. Persons who became infected during adulthood were most likely
to respond to this treatment. Long-term follow up of treated patients
suggests that remission of chronic HBV from treatments with interferon
is of long duration. Talk to your health care provider about the use
of Interferon.
-
Lamivudine (Epivir)
is now available to treat chronic HBV. It is the first medication specifically
formulated to do so. Talk to your health care provider for more information
about lamivudine and to learn if it is right for you.
-
Adefovir dipivoxil
(Hepsera), is the first nucleotide analog approved to treat chronic
HBV. Adefovir dipivoxil slows the progression of chronic HBV by interfering
with the virus' replication process within the body. Results show that
adefovir dipivoxil can significantly reduce liver inflammation and scarring.
It has been shown to work in people who have resistance to the drug
lamivudine. Consult your health care provider for more information about
adefovir dipivoxil and to learn it is right for you.

Why
worry about hepatitis B?
Hepatitis B can cause:
- Chronic infection
- Cirrhosis (scarring)
of the liver
- Liver cancer
- Death
The good news is
that hepatitis B is preventable through vaccination. A person can
choose to be vaccinated and no longer have to worry about being infected
with HBV.

Do
I need to talk to my partner about hepatitis B?
Yes. If you have an acute or chronic hepatitis B infection, you should discuss it with your partner so that he or she can learn how to protect themselves from becoming infected with HBV.

Should
I talk to my health care provider about hepatitis B?
Yes. Since hepatitis B is a preventable disease through vaccination, it
is a good idea to talk to your health care provider about whether the
vaccine is right for you.
If you find out you have been
exposed to hepatitis B, consult your health care provider as soon as possible
to discuss your best options to help prevent infection.

More
Information on hepatitis and other STD's
For additional questions about this or any other STD's and other diseases,
CDC (Centers for Disease Control) provides several toll-free hotlines for public
use. The hotlines provide referrals and more answers to your questions. Be
sure to request free printed information when you call the hotlines.
- CDC
National STD and AIDS Hotlines:
1-800-342-2437 or 1-800-227-8922. The hotlines
are open 24 hours a day, seven days a week. For Spanish
call 1-800-344-7432, 8:00 a.m. to 2:00 a.m. eastern standard time,
seven days a week. For the deaf and hard-of-hearing call
1-800-243-7889, 10:00 a.m. to 10:00 p.m. eastern standard time,
Monday through Friday.
- CDC
National Immunization Information Hotline:
English 1-800-232-2522 Spanish 1-800-232-0233 8 a.m.
to 11 p.m. eastern standard time. For the deaf and hard-of-hearing call
1-800-243-7889. Monday through Friday 10 a.m. to 10 p.m. eastern standard time.
- CDC
Public Response Hotline (CPR):
English 1-888-246-2675 span 1-888-246-2857 Monday through
Friday 8 a.m. to 11 p.m. eastern standard time 10 a.m. to 8 p.m. Saturday
and Sunday. For the deaf and hard-of-hearing 1-866-874-2646 10
a.m. to 1 p.m. eastern standard time Monday through Friday.

|